Table 1: Response to treatment in patients with
cutaneous leishmaniasis treated with meglominee antimoniate (MG) in compared
hypertonic sodium chloride solution (HSCS)
|
Treatment |
Intra lesional MG (after 6 weeks) |
Intra lesional HSCS (after 6 weeks) |
Intra lesional MG (after 10 weeks) |
Intra lesional HSCS (after 10 weeks) |
Intra lesional M`G (6 mounths follow up) |
Intra lesional HSCS (6 mounths follow up) |
|
Response |
||||||
|
Complete |
12(33/3%) |
9(25%) |
15(52%) |
9(25%) |
15(52%) |
9(25%) |
|
Partial |
16(44/4%) |
8(22/3%) |
13(25/7%) |
8(22/3%) |
- |
- |
|
No Response |
8(22/3%) |
18(50%) |
8(22/3%) |
18(50%) |
21(48%) |
26(72/3%) |
|
Total |
36(100%) |
35(97/3%) |
36(100%) |
35(97/3%) |
36(100%) |
35(97/3%) |
Missing Case=1